Life must be regulated to defeat COVID-19. Innova Medical Group’s commitment to sound science and tested medical practices provides solutions.
How do governments, national, state, and local, face the unknown, constantly changing COVID-19 pandemic and protect their communities?
To reopen society after a global pandemic, government and public health officials must stay resilient and provide a road map. Leadership, funding, coordination and a robust supply chain of test kits and vaccines can save lives. At the present time, many regions are unable to provide enough testing capacity to meet demand. This patchwork model of state-led testing is not working as many infected people have been reluctant to share their recent contacts to tracers. Local and state public health agencies are overwhelmed and lack the digital tools to securely transmit testing results into central reporting databases at the U.S. Centers for Disease Control (CDC) and the Department of Health and Human Services (HHS).
Without a uniform testing protocol in place, health officials will not know where the coronavirus lurks, and be unable to isolate the infected and trace their contacts. Having the tools, such as INNOVA’s rapid antigen and antibody tests, available at convenient point-of-care settings to see if one is infectious, must be a high priority. Communities can use COVID-19 testing result numbers to calculate the percentage of people who test positive, a key metric on future outbreak spread. Under Innova’s end-to-end COVID-19 Testing Solutions, real-time data is evaluated against various strategies to build a collaborative approach. With Testing, Implementation, Monitoring and Engagement, Innova’s Four Pillars of Success can become the road map.